| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02707900 Details | 2019-10-07 Interventional | 1 | 6 | Vorinostat Communicable Di… HIV Infections Infections HIV-1 Infection | Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided. - | |||
| NCT02433587 Details | 2019-10-07 Interventional | 3 | 0 | Aspirin Clopidogrel Peripheral Arte… Peripheral Vasc… Endovascular Pr… | Never recruited any patients. - | |||
| NCT01230476 Details | 2019-10-07 Interventional | 2 | 3 | Cetuximab Carcinoma Nasopharyngeal … | - - | |||
| NCT03823417 Details | 2019-10-04 Interventional | 4 | 0 | Tranexamic Acid Hemorrhage Bleeding | Investigators decided not to begin the study. - | |||
| NCT03729284 Details | 2019-10-04 Interventional | 4 | 0 | Duloxetine Hydr… Healthy | This study has been cancelled prior to FSFV due to business reasons - | |||
| NCT03051711 Details | 2019-10-04 Interventional | 1 | 14 | Pyrazole Hypoxia Cardio-pulmonar… | Sponsor discontinued IPF Program on 23-Oct. 2017 based on POC studies - | |||
| NCT01482559 2010-023988-17 Details | 2019-10-02 Interventional | 3 | 58 | Dopamine Hemorrhage Hypotension Intraventricula… Low Blood Press… | Study ceased enrolling due to poor overall recruitment. Long-term follow up of enrolled
participants ongoing. - | |||
| NCT00732251 Details | 2019-10-02 Interventional | 4 | 15 | Allopurinol Bipolar Disorde… Mania Mixed Mania | The outpatient area of the department of psychiatry at CSMC closed. - | |||
| NCT02370095 Details | 2019-10-01 Interventional | 2 | 14 | Pharmaceutical … Treprostinil Acute Lung Inju… Respiratory Dis… Respiratory Dis… Respiratory Dis… | - The study was stopped because of low recruitment. The limited number of subjects make it difficult to draw conclusions regarding the efficacy of Treprostinil in subjects at high risk of developing ARDS. | |||
| NCT03417076 Details | 2019-09-30 Interventional | 1 | 0 | Bexagliflozin Diabetes Mellit… Type 2 Diabetes… | Sponsor decision to not initiate study due to sufficient bioavailability information - | |||
| NCT02198209 Details | 2019-09-30 Interventional | 4 | 0 | Liraglutide Type 2 Diabetes | Investigator decided not to move forward with study prior to study start date - | |||
| NCT03794154 Details | 2019-09-27 Interventional | 4 | 0 | Duloxetine Hydr… Malnutrition Healthy | This study has been cancelled prior to FSFV due to business reasons - | |||
| NCT02941601 2016-002041-31 Details | 2019-09-27 Interventional | 2 | 0 | Carboplatin Gemcitabine Necitumumab Carcinoma, Non-… Lung Neoplasms Locally Advance… Metastatic Squa… | This was a strategic decision for business planning purposes and not out of concern for patient
safety. - | |||
| NCT02881567 2016-002820-10 Details | 2019-09-27 Interventional | 3 | 41 | Daclizumab Multiple Sclero… Multiple Sclero… Sclerosis Relapsing-Remit… | Study terminated in line with Biogen decision to withdraw Zinbryta from the market and not to
pursue further studies of daclizumab in MS. - | |||
| NCT02447887 Details | 2019-09-26 Interventional | 1/2 | 3 | Interferon alph… Ixazomib Carcinoma Carcinoma, Rena… Metastatic Rena… RCC | IRB study closure facilitated by Investigator - | |||
| NCT01451606 Details | 2019-09-26 Interventional | 4 | 34 | Duloxetine Hydr… Pelvic Pain Pelvis Pain Chr… | Adequate recruitment was not achieved in the time frame allowed. - | |||
| NCT00925119 Details | 2019-09-26 Interventional | 4 | 31 | Atenolol Diabetes Mellit… | - - | |||
| NCT03245385 Details | 2019-09-25 Interventional | 2 | 20 | Halobetasol Dermatitis Dermatitis, Ato… Eczema Atopic Dermatit… | Sponsors decision - | |||
| NCT02979392 Details | 2019-09-25 Interventional | 1 | 19 | Paclitaxel Advanced Solid … | - - | |||
| NCT01524575 Details | 2019-09-25 Interventional | 2 | 0 | Gemcitabine Oxaliplatin Pancreatic Neop… ERCC1 Metastatic Panc… | the trial was never opened and then withdrawn permanently - |